Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
- Citation:
- J Transl Med vol 10 246
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 2
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- T. F. Gajewski A. K. Salama D. Niedzwiecki J. Johnson G. Linette C. Bucher M. A. Blaskovich S. M. Sebti F. Haluska
- Networks:
- Study
- CALGB-500104
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: